ISSN: 1176-6336

Journal Home

Therapeutics and Clinical Risk Management Q1 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Therapeutics and Clinical Risk Management is a journal indexed in SJR in Medicine (miscellaneous) and Safety Research with an H index of 70. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on clinical therapeutics, clinical risk management. It has an SJR impact factor of 0,752 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,752.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) Safety Research (Q1) Chemical Health and Safety (Q2) Medicine (miscellaneous) (Q2) Pharmacology (medical) (Q2)

Price

2079 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Therapeutics and Clinical Risk Management

0,752

SJR Impact factor

70

H Index

90

Total Docs (Last Year)

357

Total Docs (3 years)

4189

Total Refs

986

Total Cites (3 years)

352

Citable Docs (3 years)

2.35

Cites/Doc (2 years)

46.54

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Clinical therapeutics Clinical risk management

Best articles by citations

Azacytidine (Vidaza') in the treatment of myelodysplastic syndromes

Clinical implications of changes in hepatic drug metabolism in older people

Optimizing use of opiates in the management of cancer pain

Comparison of echinocandin antifungals

The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma

Natalizumab: A new treatment for relapsing remitting multiple sclerosis

Willingness-to-pay for caregivers of children with asthma or wheezing conditions

What do parents want from their child's asthma treatment?

Long-term management of gastroesophageal reflux disease with pantoprazole

The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?

Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia

Nonsteroidal antiinflammatory drugs (NSAIDs) and physiotherapy management of musculoskeletal conditions: a professional minefield?

SHOW MORE ARTICLES

Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B

Acute postoperative pain management: focus on iontophoretic transdermal fentanyl

Voriconazole in the management of nosocomial invasive fungal infections

Cost-benefit analysis of influenza vaccination in a public healthcare unit

Renal replacement therapy in the intensive care unit

The controversy surrounding OxyContin abuse: issues and solutions

A review of studies of adherence with antihypertensive drugs using prescription databases

Efficacy ofBacillus clausiispores in the prevention of recurrent respiratory infections in children: a pilot study

Exjade' (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion